Humanized IN MATRICO(TM) Lung Fibrosis Assay provides insight into efficacy of drug candidates consistent with clinical results, increasing predictiveness and accelerating decision making in development of drugs for lung fibrosis NEW YORK — Xylyx Bio, a pioneer in advanced biological systems for drug development, today announced availability of products that recreate the lung environment in vitro to provide a […]
Turin-Italy and Utrecht-the Netherlands — The ultra-modern Department of Molecular Biotechnology and Health Sciences of the University of Turin has acquired MILabs cutting edge multi-modality VECTor6CT molecular imaging system. The high-resolution and ultra-sensitive PET, SPECT and CT modalities will be used by UNITO to optimize the targeting vectors of novel probes for disease diagnostics and […]
Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion SAN ANTONIO, TX – Investigators exploring chondrocytes in vitro have the ability to study a more biologically-relevant phenotype with CELLvo™ Human Articular Chondrocytes from StemBioSys. Isolated from healthy donors, CELLvo™ Chondrocytes are available to scientists before being cultured at passage 0, or […]
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes Supports global efforts to develop therapeutics, diagnostic assay components and vaccines to combat the COVID-19 Coronavirus pandemic Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene […]
Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its COVID-19 vaccine candidate, ChAdOx1 nCoV-19. DARMSTADT, GERMANY Recently developed manufacturing platform allows large-scale manufacturing Joint team reduced process development time to two months from a year – a critical step to manufacturing COVID-19 vaccine at […]
Bournemouth, UK and Newark, CA, USA – Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening orders of magnitude fewer […]
Columbia, Missouri, USA and Utrecht, the Netherlands Harry S. Truman Memorial Veterans’ Hospital’s research program is nationally recognized, in part, because of its Biomolecular Imaging Center (BIC). Using the latest imaging technology, researchers at Truman VA’s BIC conduct preclinical and translational studies to improve the lives of Veterans and all Americans through health care discovery […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the […]
New structure to enhance company’s focus on customers, disruptive innovation, and growth; Chief operating officer to drive operational excellence CORNING, N.Y. — Corning Incorporated announced on Wednesday that it is reorganizing its operating structure based on extensive analysis and leadership review. The new structure aligns executive management and business teams around five Market-Access Platforms (MAPs): […]
SAN DIEGO — Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) announced today that it has terminated the merger agreement with Tarveda Therapeutics, Inc. (“Tarveda”), originally announced on December 16, 2019, and will continue to operate as an independent company. The Company had submitted the merger proposal and other related proposals to be voted upon at a Special Meeting of Stockholders, as described […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
